Generic Medicine Info
Description: Etamivan has actions similar to dozapram. It was formerly used as a resp stimulant, but the risk of toxicity associated with effective doses is now considered to be unacceptable. It is available in oral preparations for use in cerebrovascular and circulatory disorders and hypotension, but it is no longer recommended.
MIMS Class
Respiratory Stimulants
Disclaimer: This information is independently developed by MIMS based on Etamivan from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 MIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in